Trial Profile
A Study of Aezea (Cenersen) in Transfusion Dependent Anemia Associated With Myelodysplastic Syndrome
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Cenersen (Primary) ; Dexamethasone
- Indications Myelodysplastic syndromes
- Focus Adverse reactions
- Sponsors Eleos
- 18 Feb 2021 Status changed from recruiting to discontinued.
- 24 Sep 2014 New trial record